| 2023 |
Novel insights into cancer stem cells targeting: CAR-T therapy and epigenetic drugs as new pillars in cancer treatment |
Articolo in rivista |
Vai |
| 2023 |
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells |
Articolo in rivista |
Vai |
| 2023 |
EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas |
Articolo in rivista |
Vai |
| 2023 |
Editorial: CAR T-cells: novel therapeutic approaches in the new era of cancer immunotherapy |
Articolo in rivista |
Vai |
| 2022 |
Targeting epigenetic alterations in cancer stem cells |
Review essay (rassegna critica) |
Vai |
| 2022 |
Correlative Raman–Electron–Light (CREL) Microscopy Analysis of Lipid Droplets in Melanoma Cancer Stem Cells |
Articolo in rivista |
Vai |
| 2022 |
Editorial: The effects of chemotherapy towards the tumor microenvironment |
Nota o commento |
Vai |
| 2022 |
Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy |
Review essay (rassegna critica) |
Vai |
| 2022 |
Cancer cell targeting by CAR-T cells: A matter of stemness |
Review essay (rassegna critica) |
Vai |
| 2022 |
Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy |
Review essay (rassegna critica) |
Vai |
| 2022 |
Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51 |
Articolo in rivista |
Vai |
| 2022 |
Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells |
Articolo in rivista |
Vai |
| 2021 |
Cancer stem cell biomarkers predictive of radiotherapy response in rectal cancer: A systematic review |
Review essay (rassegna critica) |
Vai |
| 2021 |
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells |
Articolo in rivista |
Vai |
| 2021 |
Magnetic Nanoparticle-Based Hyperthermia Mediates Drug Delivery and Impairs the Tumorigenic Capacity of Quiescent Colorectal Cancer Stem Cells |
Articolo in rivista |
Vai |
| 2021 |
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery |
Articolo in rivista |
Vai |
| 2021 |
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin |
Articolo in rivista |
Vai |
| 2021 |
Nobiletin and Xanthohumol Sensitize Colorectal Cancer Stem Cells to Standard Chemotherapy |
Articolo in rivista |
Vai |
| 2021 |
Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome |
Articolo in rivista |
Vai |
| 2021 |
Targeting Phosphatases and Kinases: How to Checkmate Cancer |
Articolo in rivista |
Vai |
| 2020 |
Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis |
Articolo in rivista |
Vai |
| 2020 |
Metabolic Escape Routes of Cancer Stem Cells and Therapeutic Opportunities |
Review essay (rassegna critica) |
Vai |
| 2020 |
Nodular morphea keloidal type: A rare case with paradigmatic histopathology significantly accompanied by a flawless surgical scar |
Articolo in rivista |
Vai |
| 2019 |
Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway |
Articolo in rivista |
Vai |
| 2019 |
Meeting the Challenge of Targeting Cancer Stem Cells |
Articolo in rivista |
Vai |
| 2019 |
Cancer Stem Cells: From Birth to Death |
Capitolo o Saggio |
Vai |
| 2018 |
MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state |
Articolo in rivista |
Vai |
| 2017 |
Squamous cell tumors recruit γδ T cells producing either IL17 or IFNγ depending on the tumor stage |
Articolo in rivista |
Vai |
| 2017 |
IL4 primes the dynamics of breast cancer progression via DUSP4 inhibition |
Articolo in rivista |
Vai |
| 2017 |
Role of Type I and II interferons in colorectal cancer and melanoma |
Recensione in rivista |
Vai |
| 2016 |
ΔNp63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis |
Articolo in rivista |
Vai |
| 2015 |
Targeting cancer stem cells and the tumor microenvironment |
Capitolo o Saggio |
Vai |
| 2015 |
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance |
Articolo in rivista |
Vai |
| 2013 |
Erythropoietin activates cell survival pathways in breast cancer stem-like cells to protect them from chemotherapy |
Articolo in rivista |
Vai |
| 2013 |
Tumor and its microenvironment: a synergistic interplay. |
Recensione in rivista |
Vai |
